SEC Form 3 · accession 0001470831-26-000771
Braveheart Bio, Inc. · BRVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason V Coloma
Director
Period of report
Aug 5, 2026
Accepted (ET)
Aug 5, 2026 · 9:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002131524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 93,607 | I | By The Coloma 2021 Irrevocable Family Trust f/b/o Miles Coloma u/a/d 9/20/2021 | |
| Common StockF1 | holding | — | — | — | 93,607 | I | By The Coloma 2021 Irrevocable Family Trust f/b/o Jared Coloma u/a/d 9/20/2021 | |
| Common StockF1 | holding | — | — | — | 913,242 | I | By Westport Meridian Capital LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person disclaims beneficial ownership of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Remarks
Exhibit 24 - Power of Attorney